Clinical Trial Update: Insulin Signaling in Skeletal Muscle [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial on insulin signaling in skeletal muscle was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Sensitivity

Snippet

Sponsor: Wayne State University | Conditions: Insulin Sensitivity | Phase 2, Phase 3 | Status: WITHDRAWN